Increasing the Chemical Space of L-SIGN Specific Glycomimetics.
Cavazzoli, G., Delaunay, C., Pollastri, S., Panzeri, A., Sattin, S., Thepaut, M., Belvisi, L., Fieschi, F., Bernardi, A.(2025) J Med Chem 68: 22530-22546
- PubMed: 41108276 Search on PubMedSearch on PubMed Central
- DOI: https://doi.org/10.1021/acs.jmedchem.5c01448
- Primary Citation Related Structures: 
9G6W - PubMed Abstract: 
Selective ligands for the C-type lectin receptor L-SIGN offer promising avenues in antiviral therapies and for tissue-specific delivery. We recently reported that a guanidine-bearing modified mannose glycomimetic, called Man84 , binds to L-SIGN with micromolar affinity and high-selectivity against the homologue lectin DC-SIGN. Here we describe a series of Man84 isosteres (ligands 2-11 ) that maintain or improve on this selectivity. The affinity of the ligands for L-SIGN, as well as their selectivity against DC-SIGN, were evaluated by Surface Plasmon Resonance inhibition assays using immobilized SARS-CoV-2 Spike protein. Compounds 4 , 5 and 9 were found to bind to L-SIGN with low micromolar affinity and 50-94-fold selectivity, thus matching or exceeding the performance of Man84 . The crystal structure of the L-SIGN CRD/ 4 complex was solved and highlighted the critical role of a bidentate H-bond interaction of the ligands with the side chain of E370 in L-SIGN.
- Dipartimento di Chimica, Università degli Studi di Milano, via Golgi 19, Milano 20133, Italy.
Organizational Affiliation: 
















